EFFICACY OF ENDOSCOPIC TREATMENT FOR PRIMARY VESICO-URETERIC REFLUX IN CHILDREN

Authors

  • Muhammad Athar Khwaja Pakistan Kidney Institute, Shifa International Hospital, Islamabad
  • Gul Nawaz Pakistan Kidney Institute, Shifa International Hospital, Islamabad
  • Muhammad Imran Jamil Pakistan Kidney Institute, Shifa International Hospital, Islamabad
  • Shujah Muhammad Pakistan Kidney Institute, Shifa International Hospital, Islamabad
  • Asad ur Rehman Pakistan Kidney Institute, Shifa International Hospital, Islamabad
  • Durre Shohab Pakistan Kidney Institute, Shifa International Hospital, Islamabad
  • Iftikhar Ali Khan Pakistan Kidney Institute, Shifa International Hospital, Islamabad
  • Ijaz Hussain Pakistan Kidney Institute, Shifa International Hospital, Islamabad
  • Waqas Iqbal Pakistan Kidney Institute, Shifa International Hospital, Islamabad
  • Saeed Akhter Pakistan Kidney Institute, Shifa International Hospital, Islamabad

Abstract

Background: Vesicoureteral reflux (VUR) is a common anomaly affecting 1–3% of all children and 30–50% of those with urinary tract infection (UTI). In the past febrile vesicoureteric reflux on chronic antibiotic prophylaxis were treated by open surgery. Now a day’s endoscopic injection of a bulking material has replaced open surgical procedure in cases of primary VUR. Our objective was to assess the efficacy of endoscopic treatment for primary vesico-ureteric reflux in children. Methods: This was a descriptive case series. One hundred and five patients with either unilateral or bilateral VUR (181ureters) underwent endoscopic treatment for primary VUR between January 2011 and January 2014. Children from 1 to 12 years of age with grade-II to IV reflux on preoperative voiding cystourethrogram (VCUG) were enrolled through consecutive non-probability sampling. Efficacy of treatment was evaluated at three months post injection by a standard VCUG. Ureters with no or grade-I reflux were considered successful treatment. Results: Out of 105 patients 76 had bilateral while 29 had unilateral reflux. Mean age was 5.7 years (SD±.7). Among 181 refluxing ureters, 116 (64%) were free of reflux, while 49 (27%) showed down gradation and 16 (8.8%) showed no response to treatment on postoperative VCUG. Conclusion: Endoscopic treatment for VUR is a viable option for patients with primary VUR and may be considered in management of such cases.

References

Sorensen MD, Koyle MA, Cowan CA, Zamilpa I, Shnorhavorian M, Lendvay TS. Injection volumes of dextranomer/hyaluronic acid are increasing in the endoscopic management of vesicoureteral reflux. PediatrSurgInt 2010;26:509–13.

Fanos V, Cataldi L. Antibiotics or surgery for vesicoureteric reflux in children. Lancet 2004;364(9446):1720–2.

Sargent MA. What is the normal prevalence of vesicoureteral reflux? PediatrRadiol 2000;30(9):587–93.

Knudson MJ, Austin JC, McMillan ZM, Hawtrey CE, Cooper CS. Predictive factors of early spontaneous resolution in children with primary vesicoureteral reflux. J Urol 2007;178(4 Pt 2):1684–8.

Yeung CK, Sreedhar B, Sihoe JD, Sit FK. Renal and bladder functional status at diagnosis as predictive factors for the outcome of primary vesicoureteral reflux in children. J Urol 2006;176(3):1152–6.

Sjöström S, Sillén U, Jodal U,Sameby L, Sixt R, Stokland E. Predictive factors for resolution of congenital high grade vesicoureteral reflux in infants: results of univariate and multivariate analyses. J Urol 2010;183(3):1177–84.

Bae YD, Park MG, Oh MM, Moon du G. Endoscopic subureteral injection for the treatment of vesicoureteral reflux in children: polydimethylsiloxane (Macroplastique) versus dextranomer/hyaluronic acid copolymer (Deflux). Korean J Urol 2010;51:128–31.

PuriP, Chertin B, Velayudham M, Dass L, Colhoun E. Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic acid copolymer: preliminary results. J Urol 2003;170(4 Pt 2):1541–4.

Matouschek E. Treatment of vesicorenal reflux by transurethral Teflon-injection. Urologe A 1981;20(5):263–4.

O’Donnell B, Puri P. Treatment of vesicoureteric reflux by endoscopic injection of Teflon. Br Med J (Clin Res Ed) 1984;289(6436):7–9.

Kirsch AJ, Perez-Brayfield M, Smith EA, Scherz HC: The modified sting procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol 2004;171(6 part 1):2413–6.

Chertin B, Colhoun E, Velayudham M, Puri P. Endoscopic treatment of vesicoureteral reflux: 11 to 17 years of followup. J Urol 2002;167(3):1443–5.

Capozza N, Caione P.Dextranomer/hyaluronic acid copolymer implantation for vesico-ureteral reflux: A randomized comparison with antibiotic prophylaxis. J Pediatr 2002;140(2):230–4.

Kirsch AJ, Perez-Brayfield MR, Scherz HC. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: The Children's Hospitals of Atlanta experience. J Urol 2003;170(1):211–5.

Connolly LP, Treves ST, Connolly SA, Zurakowski D, Share JC, Bar-Sever Z, et al.Vesicoureteral reflux in children: incidence and severity in siblings. J Urol 1997;157(6):2287–90.

Capozza N, Caione P.Vesicoureteral reflux: surgical and endoscopic treatment. PediatrNephrol 2007;22(9):1261–5.

Tekgül S, Riedmiller H, Hoebeke P, Kocvara R, Nijmane RJM, Radmayr R, et al. EAU guidelines on vesicoureteral reflux in children. Eur Urol 2012;62:534–42.

Puri P, Kutasy B, Colhoun E, Hunziker M. Single center experience with endoscopic subureteraldextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux. J Urol 2012;188(4 Suppl):1485–9.

Capozza N, Lais A, Nappo S, Caione P. The role of endoscopic treatment of vesicoureteral reflux: a 17-year experience. J Urol 2004;172(4 Pt 2):1626–8.

Cabezalí Barbancho D, Gómez Fraile A, LópezVázquezF, López Díaz M, Bramtot A. Our experience using various injectable materials for the endoscopic treatment of vesicoureteral reflux. Arch Esp Urol 2008;61(2):269–77.

de Castro R, Massó P, Reis A. The treatment of vesicoureteral reflux. Arch EspUrol 2008;61(2):244–7.

Routh JC, Inman BA, Reinberg Y. Dextranomer/hyaluronic acid for pediatric vesicoureteral reflux: systematic review. Pediatrics 2010;125(5):1010–9.

Rivilla F. Endoscopic treatment of vesicoureteral reflux in a paediatric surgery ambulatory unit. J Minim Access Surg 2011;7(2):132–5.

Neel KF. Endoscopic correction of vesicoureteric reflux: 10-year experience of a tertiary care center. Saudi J Kidney Dis Transpl 2012;23(1):48–52.

Lorenzo AJ, Pippi Salle JL, Barroso U, et al: What are the most powerful determinants of endoscopic vesicoureteral reflux correction? Multivariate analysis of a single institution experience during 6 years. J Urol. 2006; 176(4 Pt 2):1851-5.

Coletta R, Olivieri C, BrigantiV, Perrotta ML, Oriolo L, Fabbri F, et al. Patients with a history of infection and voiding dysfunction are at risk for recurrence after successful endoscopic treatment of vesico ureteral reflux and deserve long-term follow up. Urol Ann 2012; 4(1):19–23. Ref no 20&28 are same

Seibold J, Werther M, Alloussi SH, Aufderklamm S, Gakis G, Todenhöfer T, et al. Long-term results after endoscopic VUR-treatment using dextranomer/hyaluronic acid copolymer – 5-year experience in a single-center. Cent European J Urol 2011;64(2):84–86.

Chertin B, Kocherov S, Chertin L, Natsheh A, Farkas A, Shenfeld OZ, et al. Endoscopic Bulking Materials for the Treatment of Vesicoureteral Reflux: A Review of Our 20 Years of Experience and Review of the Literature. Adv Urol 2011;2011:309626.

Dewan PA, Goh DW. Subureteric Polytef injection in the management of vesico-ureteric reflux in children. J Paediatr Child Health 1994;30(4):324–7.

Holmdahl G, Brandström P, LäckgrenG, Sillén U, Stokland E, Jodal U, et al. The Swedish reflux trial in children: II. Vesicoureteral reflux outcome. J Urol 2010;184(1):280–5.

Vandersteen DR, Routh JC, Kirsch AJ, Scherz HC, Ritchey ML, Shapiro E, et al. Postoperative ureteral obstruction after subureteral injection of dextranomer/hyaluronic acid copolymer. J Urolo 2006;176(4 Pt 1):1593–5.

Cerwinka WH, Scherz HC, Kirsch AJ. Endoscopic Treatment of Vesicoureteral Reflux with Dextranomer/Hyaluronic Acid in Children. Adv Urol 2008;2008:513854.

Published

2015-12-15

Issue

Vol. 27 No. 4 (2015): Journal of Ayub Medical College, Abbottabad

Section

ORIGINAL ARTICLE

License

Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License  CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.

USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.

AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.

Most read articles by the same author(s)

<< < 1 2